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ReviewRegenerative medicine is an emerging multidisciplinary
field that aims to restore, maintain or enhance tissues
and hence organ functions. Regeneration of tissues can
be achieved by the combination of living cells, whichwill
provide biological functionality, andmaterials, which act
as scaffolds to support cell proliferation. Mammalian
cells behave in vivo in response to the biological signals
they receive from the surrounding environment,which is
structured by nanometre-scaled components. Therefore,
materials used in repairing the human body have to
reproduce the correct signals that guide the cells
towards a desirable behaviour. Nanotechnology is not
only an excellent tool to producematerial structures that
mimic the biological ones but also holds the promise of
providing efficient delivery systems. The application of
nanotechnology to regenerativemedicine is awide issue
and this short review will only focus on aspects
of nanotechnology relevant to biomaterials science.
Specifically, the fabrication of materials, such as nano-
particles and scaffolds for tissue engineering, and the
nanopatterning of surfaces aimed at eliciting specific
biological responses from the host tissue will be
addressed.Introduction
Regenerative medicine has brought high expectations for a
great number of current worldwide human illnesses. Dis-
eases, such as Parkinson’s disease, Alzheimer’s disease,
osteoporosis, spine injuries or cancer, might in the near
future be treated with methods that aim at regenerating
diseased or damaged tissues. The perspective of regener-
ating damaged or nonfunctional tissues by using an off-the-
shelf synthetic product is a drive for medical science.
Today’s interest in nanomedicine keeps growing because
the application of nanotechnology tools to the development
of structures at the molecular level enables the improve-
ment of the interactions between material surfaces and
biological entities. Although cells have micrometre dimen-
sions, they evolve in vivo in close contact with the extra-
cellular matrix (ECM), a substratum with topographical
and structural features of nanometre size. The interactions
between cells and the ECM influence cell growth, guide cell
mobility and affect the general behaviour of cells. Nano-
technologies provide the possibility to produce surfaces,Corresponding author: Planell, J.A. (Josep.A.Planell@upc.edu).
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mimic the natural environment of cells, to promote certain
functions, such as cell adhesion, cell mobility and cell
differentiation.
Nanomaterials used in biomedical applications include
nanoparticles for molecules delivery (drugs, growth fac-
tors, DNA), nanofibres for tissue scaffolds, surface modifi-
cations of implantable materials or nanodevices, such as
biosensors. The combination of these elements within
tissue engineering (TE) is an excellent example of the
great potential of nanotechnology applied to regenerative
medicine. The ideal goal of regenerative medicine is the in
vivo regeneration or, alternatively, the in vitro generation
of a complex functional organ consisting of a scaffold made
out of synthetic or natural materials that has been loaded
with living cells (Figure 1). Ideally, stem cells are to be
used owing to their ability to generate all types of tissues
and their unlimited self-renewal capacity. The functiona-
lisation of such a porous scaffold with different biomole-
cules (depending on the targeted cells) or the entrapment of
nanoparticles, such as growth factors, drugs or genes, could
enhance the success of the TE strategy greatly. However,
crucial issues, such as stem cell isolation from the patient
and their proliferation, the culturing process in a bio-
reactor and the time delay before the engineered hybrid
construct is implanted back into the patient, present major
difficulties to this approach becoming a well established
standardised procedure in the near future.
The aim of this article is to review the aspects related to
the materials used currently for tissue regeneration and it
will furthermore point out themost promising strategies in
the field. Other equally important issues, such as cell
therapies or diagnostic applications, fall out of the scope
of this review and will not be addressed.
Nanofeatures on surface biomaterials
As discussed earlier, the behaviour of cells depends on
their interactions with the environment. Consequently,
the interactions between cells and implantable materials
will determine the success or failure of a medical device. It
is well known that cell response is affected by the physi-
cochemical parameters of the biomaterial surface, such as
surface energy, surface charges or chemical composition.
Topography is one of the most crucial physical cues for
cells. Microtopography influences cell adhesion, prolifer-
ation and differentiation [1,2] and, more recently, it
has become clear that nanotopography also guides cell07.10.005 Available online 26 November 2007 39
Figure 1. Tissue engineering approach for tissue regeneration. Two different strategies exist for regenerative medicine: in vivo or in vitro regeneration of the living tissue.
Both methods use a porous scaffold that is loaded with cells. Topographical structure at the nanometre scale can be generated onto the scaffold surface. The scaffold can
also be functionalised with different molecules to enhance cell functions. Components, such as drugs, genes, peptide sequences, such as arginine–glycine–aspartic acid
(RGD), or proteins, can be entrapped into nanoparticles and released subsequently in a controlled manner to reach a specific target, such as cells, bacteria and viruses.
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guiding the cell orientation is essential to achieve a func-
tional tissue, such as for tendons, nerves, corneal stroma
and intervertebral-disc regeneration, contact guidance of
cells by micro- and nano-topographical patterns is a prom-
ising perspective [5,6]. Chemical cues in the form of various
different biomolecules (nanometre scale), such as adhesive
protein or growth factors, also influence cell behaviour
crucially. For example, fibronectin and laminin are able
to enhance the adhesion of different cell types. Therefore,
considerable efforts have been made to modify biomaterial
surfaces chemically by immobilisation of these biomole-
cules [7,8].
Nanopattern fabrication
Because nanotopography seems to have an essential role in
guiding cell behaviour in vivo, it is now being used in
biomaterials science as a tool for controlling tissue regen-
eration. A wide variety of techniques have been used to
produce nanotopography on biomaterial surfaces. Methods
leading to an ordered topography with a regular controlled
pattern and methods leading to unordered topography
with random orientation and organisation have been
developed and are described in Box 1. Polymer demixing,
chemical etching and colloidal lithography are some of the
most relevant techniques to obtain randomly organised
patterns. Conversely, soft-lithography techniques and ot-
her methods using different sources of radiation (electrons,
ions or photons) to etch the substrate are among the
techniques used most commonly to produce regular geo-
metries. Figure 2 shows how specific nanostructured sur-
faces can be used to control the growth of mesenchymal
stem cells (MSCs).40All the techniques of nanostructuration cited here can
be combined with self-assembly for functionalisation of the
surface (refer to later in the text for the definition and
relevance of self-assembly). For example, the creation of a
nonfouling surface, which can be useful in ophthalmologi-
cal and cardiovascular application, can be achieved by the
functionalisation of metal surfaces (e.g. Au) with alka-
nethiol self-assembled molecules, which can bind poly(-
ethylene-glycol) molecules. Finally, dip-pen lithography
is a simple method to create chemical patterns at the
nanoscale (Box 1).
Nanocoatings and nanophase materials
Nanophase materials (i.e. materials with nanometre-
scaled grains) can be used to produce nanometre features
on biomaterial surfaces to guide cell behaviour along a
desired biological response [9,10]. In bone-regeneration
applications, promising results have been obtained with
the nanophase materials ceramics and metals, with which
increased osteoblast adhesion, proliferation and calcium
deposition have been observed compared with convention-
al materials (i.e. with micrometre-scaled grains) [11].
Nanophase materials can also be deposited on a bioma-
terial surface to improve its bioactivity and/or biocompat-
ibility. For example, nanocrystalline apatite coatings,
produced by sol-gel methods or pulse electrodeposition
[12,13], are used commonly to enhance the osteointegration
of anorthopaedicdevice.Other techniques, suchas layer-by-
layer assembly (LBL) deposition [14,15], lead to nanocoat-
ings (a few nanometres thick) with a controlled structure by
sequential adsorption of oppositely charged polyelectro-
lytes. LBL can be useful for drug-delivery systems [16]
and surface functionalisation of biomaterial surfaces [14].
Box 1. Methods for topographical and chemical surface modification
Soft lithography
Soft lithography is the general term for different techniques based on
the use of an elastomeric stamp [which is made of poly(dimethylsi-
loxane) (PDMS) most commonly] to structure a material surface. This
stamp is produced by using a master with a specific pattern (for more
details, refer to [48]) and is then used to reproduce the pattern on a
substrate.
 Microtransfer moulding: See Figure Ia for details.
 Replica moulding: The PDMS pattern is used as a mould for casting
another polymer, which, after curing, will give a negative replica of
the PDMS.
 Micromoulding in capillaries: A PDMS stamp is placed on the
substrate to be patterned to form a network of empty channels
between the substrate and the stamp. A drop of polymer is placed
at one end of the channels and then the channels are filled by
capillarity. The PDMS stamp is removed after curing.
 Solvent-assisted micromoulding: A solvent is used to wet the
PDMS stamp, which is then placed against the substrate. The
substrate is dissolved by the solvent and the resulting fluid is
moulded in the PDMS pattern. After evaporation of the solvent and
solidification of the substrate, a complementary structure to that of
PDMS is obtained.
 Microcontact printing: See Figure Ib for details. This is used to
transfer molecules from the stamp to a substrate in a controlled
geometry.
Colloidal lithography
This uses a nanocolloidal solution to act as an etch mask. The solution
is dispersed as a monolayer on a substrate and self-assembles
electrostatically. The surrounding area of the nanocolloid particles
(and also of the particles themselves) is etched by reactive ion-beam
bombardment, thus creating a pattern on the substrate.
Hot embossing
A rigid stamp (usually made of silicon) is pressed against a softened
polymer film to produce a pattern.
E-beam or ion-beam (EUV) lithography
This uses particle exposure of a sensitive resist to produce a pattern
that can be revealed chemically in a second step or used directly to
initiate polymer grafting.
Dip-pen lithography
This is a direct-write method in which an AFM tip is used in tapping
mode to transfer molecules (e.g. proteins, polymers) to a target
region of the substrate directly.
Polymer demixing
This is based on spontaneous phase separation of a polymer mixture
under the spin-casting process onto a substrate (silicon, glass). The
shape (pit, island, ribbon) and size of the features can be modulated
by either changing the polymer ratio or the polymer concentration. A
precise control of the height of the features (vertical direction) can be
achieved (feature size >13 nm).
Figure I. (a) Microtransfer moulding. (b) Microcontact printing.
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Numerous in vitro and in vivo studies, using nanostruc-
tured materials, have demonstrated the validity of this
approach for a variety of cell types. The results of the
relevant studies confirmed the potential of nanostructures
in regenerating different tissues (such as bone, cartilage,
bladder, nerves and vessels) by enhancing the biological
performance of the cells (e.g. increased adhesion, prolifer-
ation, migration). A summary of some of these applications
is given in Table 1.
Materials for nanoparticles
Nanoparticle research within regenerative medicine has
been addressedmainly towards the development of entrap-
ment and delivery systems for genetic material, biomole-
cules, such as growth and differentiation factors, and bone
morphogenetic proteins and also as reinforcing- or bioac-
tivity-enhancement phase for polymeric matrices in 3D
scaffolds for TE.
Controlled delivery of biomolecules is crucial in the
support and enhancement of tissue growth in TE appli-
cations. Nanotechnology approaches in delivery systems
can enhance the success of specific therapeutic agents,
such as growth factors and DNA among others, whichare of paramount importance for tissue regeneration
[17]. Carriers in the nanoscale enable the intracellular
delivery ofmolecules and the possibility of reaching targets
that are inaccessible normally, such as the blood–brain
barrier, tight junctions and capillaries, whereas the control
over biomolecule dosage and delivery period are increased.
The ultimate challenge is to develop artificial nanocarriers
that can target cells with efficiency and specificity similar
to that of viruses [18].
Examples of nanoparticles for delivery systems include
currently microspheres, microcapsules, liposomes, micelles
and also dendrimers. The different types of nanoparticles
have been developed as solid, hollow or porous. The most
commondevelopmentmethodsaremolecular self-assembly,
nanomanipulation, bioaggregation and photochemical pat-
terning [19,20].
Biodegradable polymers are the most commonly used
materials in drug delivery. Polylactic acid (PLA), poly-
glycolic acid (PGA), polyethylene glycol (PEG) and its co-
polymers have been used widely in combination with
hydrogels to attain nanocarriers that exhibit different
release properties. Particularly important for the devel-
opment of nanoparticles for delivery purposes are ‘smart’
or ‘stimuli-responsive’ polymers that can undergo41
Figure 2. Nanopatterns on polymethylmethacrylate (PMMA) polymer and their
influence on mesenchymal stem-cell (MSC) guiding. MSCs from bone marrow
were grown on two different nanopatterned surfaces of PMMA for 48 h. (a) A
magnified detail of the nanopattern structure, which consisted of 200 nm-wide
lines. MSCs grown on this pattern show a directional alignment along the
nanostructures (c). (b) Magnification of the square shown in (d) to visualise the
pattern of 300 nm-wide posts. Cells growing on this pattern present random
distribution and morphology (d).
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on variations in temperature, pH and magnetic field.
Table 2 presents several examples of nanoparticles pro-
duced with different materials. Their applications in the
TE field depend mainly on the material properties.
Themost widely studied temperature-sensitive polymer
is poly (N-isopropylacrylamide) (PNIPAAm) [21]. Polyelec-
trolytes, such as polymethacrylic acid (PMAA) and poly-
acrylic acid (PAA), that are able to ionise under acidic or
alkaline pH present interesting characteristics for drugTable 1. A summary of nanostructured biomaterials with potentia
Application Material Results
Bone Nanophased TiO2, Al2O3 Osteoblast
enhanced;
material)
Titanium coated with nanophase apatite Promotion
on human
Tantalum coated with nanophase apatite Increased b
and uncoa
Nanophase Ti, Ti6Al4V and CoCrMo alloy Increased o
Nanostructured poly(lactide-co-glicolide) (PLGA)
by mould-casting
Increased o
Ti mesh coated with nanocrystalline
organoapatite
Accelerated
Cartilage Nanostructured PLGA by chemical etching Better chon
Nanoporous Ti produced by anodisation Increased c
Vessels Nanostructured PLGA by chemical etching Increased e
with untrea
Bladder Nanostructured PLGA, poly-ether-urethane and
poly-caprolactone by chemical etching
Greater ad
compared
Nerves Nanopatterned poly(dimethylsiloxane) by
replica moulding
Induce diff
lineage
42carriers in applications in which pH changes occur, such as
in the delivery of genetic material [22]. In the case of
genetic-material delivery, nanoscale DNA carriers must
overcome enzymatic degradation of endosomes to reach the
cell nucleus and trigger specific cascades involved in tissue
regeneration. Nanocarriers made of pH-sensitive polymers
facilitate endosomal escape and enable the development of
new nonviral genetic-material delivery systems with high
transfection efficiencies [23].
In addition to biomolecule encapsulation and delivery,
solid surface-modified nanoparticles might also be used for
regenerative purposes. Although polymers are the most
used nanoparticles in the delivery area, the use of ceramics
has also been investigated. Hydroxyapatite nanoparticles
functionalised with biomolecules could enhance osteoblast
adhesion and bone regeneration [9].
Ceramic nanoparticles and nanofibres are also suitable
in the elaboration of bio-inspired nanocomposites for bone
TE applications, acting as the reinforcing phase of a poly-
mer matrix and improving scaffold bioactivity [24].
Although the development of nanoparticles seems to
have great potential for several biomedical fields, there
has been only little progress in the attainment of effective
results in current human therapy. However, it must
be said that the use of nanoparticles also raises the need
of a comprehensive understanding of their secondary
effects and cytotoxicity once they enter the body. The
large surface area of nanoparticles makes them very
reactive in the cellular environment. Their dimensions
enable them to penetrate through the lungs, skin or
intestinal tract and they might deposit in several organs
causing adverse biological reactions [25]. Moreover, the
fact that these particles are able to penetrate the cell
membrane and reach the cell nucleus might raise some
concern about possible unknown risks attributed to the
particle nature.
Nanofibre scaffolds
The first approach of TE was to design and fabricate 3D
constructions that could mimic the structure of the tissue
that required repair [26]. These scaffolds were made usingl applications in regenerating different tissues
Refs
adhesion promoted; long-term osteoblast functions
osteoclast activity greater (comparison with conventional
[10]
of bone ingrowth and apposition (in vivo) and influence
osteoblast behaviour
[49]
one formation in comparison with conventional apatite
ted materials (in vivo)
[9]
steoblast adhesion [10,48,50]
steoblast adhesion; decreased fibroblast adhesion [51]
migration and better proliferation of osteogenic cells [52]
drocyte functions than conventional materials [53,54]
hondrocyte adhesion and migration [9]
ndothelial and smooth muscle cell densities compared
ted PLGA
[54]
hesion and proliferation of bladder smooth muscle cells
with conventional materials
[55,56]
erentiation of adult mesenchymal stem cells into neuronal [57]
Table 2. Nanoparticles and biomedical applications
Nanoparticles Applications
Titania nanoparticles Reinforcing phase in composite materials for TE scaffolds [58]
Quantum dots Amplifiers, markers, biological sensors for bioreactors and TE
Hydroxyapatite nanoparticles Reinforcing phase in composite materials for TE, biomolecule carriers [24]
Biodegradable polymer nanoparticles Targeted-delivery systems for TE, immunotherapy [19]
Stimuli-sensitive polymeric nanoparticles Biomolecule carriers, TE [22,59]
Review Trends in Biotechnology Vol.26 No.1biodegradable materials and had a porous structure that
would ensure host-cell colonisation. Among the possible
structures that could replace the natural ECM, the use of
nanofibres as scaffolds has several advantages compared
with other techniques. Nanofibres show a high surface area
and a highly interconnected porous architecture, which
facilitate the colonisation of cells in the scaffold and the
efficient exchange of nutrients and metabolic waste be-
tween the scaffold and its environment. These nanofibres
can be made of synthetic, natural or the combination of
both types of material. Several relevant methods for the
production of nanofibres that are used in TE applications
are summarised here now.
Electrospinning
Electrospinning is a simple and cost-effective fabrication
process that uses an electric field to control the deposition
of polymer fibres onto a target substrate. This system can
produce fibres with diameters ranging from several
microns down to 100 nm or less. The generated fibres
can mimic the structural profile of the proteins found in
the native ECM. Different synthetic and natural polymers
have been used as materials to create 3D matrices for
tissue repair. Some of these polymers have been studied
in terms of fibre fabrication, diameter of the fibres and
potential applications. The possibility of aligning these
fibres is of interest in terms of mimicking the ECM. Differ-
ent materials have been used to generate such fibres:
synthetic biodegradable polymers, such as poly-L-lactic
acid (PLLA) [27,28], e-caprolactone (PCL) [29], PGA [30],
and also natural polymers, such as collagen, silk and DNA.
The combination of natural and synthetic fibres has been
achieved as well. Table 3 summarises some of the
materials used and the fibres obtained.
In addition, electrospinning is able to produce both
random and aligned networks. This prospect of controlling
the orientation of fibres is a prerequirement for biomimick-
ing of natural tissues.Table 3. Nanofibres as scaffolds for TE applications
Materials Random/aligned Average diam
Synthetic polymers
PLLA Yes/Yes 50–350 nm
Poly(latide-co-glicolide) (PLGA) Yes/No 500–800 nm
PCL Yes/? 500–900 nm
PLLA-CL Yes/Yes 0.4–1.2 mm
Natural polymers
Silk (with HAP/BMP-2) Yes/No ?
Collagen Yes/Yes 250 nm
Chitosan + polyvinyl alcohol (PVA) Yes/No 170–700 nm
Chitosan + polyethylene oxide (PEO) Yes/No 38–62 nm
Fibrinogen Yes/No 320–600 nm
Abbreviation: HAP/BMP-2, hidroxyapatite/bone morphogenic protein 2.Phase separation
This process is another method for producing three-dimen-
sional scaffolds of fibres in the submicron range. Current
cutting-edge techniques use a thermally induced phase-
separation process to produce a nanofibrous foamed
material. However, this method involves several steps,
such as raw-material dissolution, gelation, solvent extrac-
tion, freezing and drying, which make this process time
consuming. The advantages of this method are that it does
not require any sophisticated equipment and that the
resulting pore sizes and morphology can be controlled by
varying the processing parameters [31,32]. The most
widely used material for phase-separation foams is biode-
gradable PLLA, which is sometimes combined with col-
lagen. Yang et al. investigated the potential of PLLA
nanofibrous scaffolds prepared by phase separation for
nerve TE applications [31]. The resulting scaffold sup-
ported cell differentiation and neurite outgrowth.
Although this technique is a good approach to mimic the
ECM, it has so far failed to control fibre orientation. The
distribution and arrangement of the ECM has a crucial
role in controlling cell shape, regulating physiological func-
tion and defining organ architecture and it is believed that
controlling the fibre orientation will increase biomimetics
[33].
Self-assembly
Self-assembly is a process in which molecules and supra-
molecular aggregates organise and arrange themselves
into an ordered structure through weak and noncovalent
bonds [34]. The use of self-assembly to generate hierarch-
ical supramolecular structures is a biomimetic strategy to
produce synthetic materials that resemble biological
ECMs, which are able to interact with cells at the molecu-
lar level to control the processes of tissue regeneration
effectively. With this technique, nanofibres can be pro-
duced using natural or synthetic macromolecules. Several
studies report promising results of this strategy. Foreter Potential applications Refs
Neural TE [28,31]
Soft tissue [30]
Cartilage TE [29]
Smooth muscle and endothelial cells; blood vessel
engineering
[60,61]
Bone tissue engineering [62]
Fibroblasts [63]
? [64]
Chondrocites and osteoblasts [65]
Cardiac fibroblasts [66]
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Review Trends in Biotechnology Vol.26 No.1example, a peptide amphiphile (chemical compound pos-
sessing both hydrophilic and hydrophobic properties)
nanofibre network could be mineralised with hydroxyapa-
tite to recreate the nanoscale structure of bone [35]. These
amphiphile nanofibres have been designed to mimic the
collagen structure-building protein-like structural motifs
that incorporate sequences of biological interest [36].
These nanofibres have been also applied to promote rapid
and selective differentiation of neural progenitor cells into
neurons [37]. Self-assembly was also used successfully to
encapsulate chondrocytes within a self-assembled peptide-
hydrogel scaffold for cartilage repair [38].
Carbon nanotubes
Although carbon nanotubes (CNs) are not strictly
nanofibres, they are another type of nanomaterial that
can be used as scaffolds for TE applications. The dis-
covery that carbon could form stable, ordered structures
other than graphite and diamond guided Iijima to dis-
cover fullerene-related CNs by using an arc-evaporation
apparatus [39]. The tubes contained at least two layers
(often many more) and ranged in outer diameter from
approximately 3 to 30 nm. Since their discovery in 1991,
they have been proposed for many TE applications owing
to their exceptional physical properties. These nanoma-
terials consist of graphite, either in a single layer (single-
walled nanotubes) or in concentric layers (multiwalled
carbon nanotubes). The unique properties of CNs, such
as the fine electronic, mechanical properties and the high
specific surface, might provide a three-dimensional
microenvironment to facilitate the use of stem cells in
tissue regeneration. [40]. CNs can be prepared by differ-
ent methods but chemical-vapour deposition (CVD) is
used most commonly. This process involves the reaction
of a metal catalyst with a hydrocarbon feedstock at high
temperatures (>7008C) [41]. The common use of Ni as
catalyst has raised serious concern about their sub-
sequent use in biomedical applications. In addition,
the lack of a scalable production technique for high-
purity CNs has impeded their use in practical appli-
cations. However, it has been possible to remove the
metal catalyst and to avoid microstructural defects by
using CVD at higher temperatures (1800–30008C) [40].
Another important issue is that CNs are not biodegrad-
able and they have to be removed once the tissue has
been replaced. CNs have the potential to be used in
clinical applications, such as scaffolds for neural
implants, because they are highly conductive and are
hence an ideal template for transmitting electrical sig-
nals to neurons [39]. Moreover, studies on bone engin-
eering have shown that CN scaffolds are good candidates
to support the differentiation of stem cells into mature
osteoblasts and the production of bone tissue [40].
Related to health safety, some concerns about using
CNs as scaffolds for TE have been raised. There are reports
that demonstrate that nanotubes could be used to separate
DNA because DNA strands wrap around CNs. A potential
application seems to be separation purposes, although the
potential consequences of CNs entering the human body
raise a reasonable worry among the scientific community
about their safe use in the humans.44Nanodevices
Recent progress in nanotechnology has led to the devel-
opment of nanodevices that can act or detect at the nanos-
cale. This technological advance has been made possible
through advances in microfabrication technology, which
was developed initially for microelectronic applications.
More recently, the fabrication of miomicro-electromecha-
nical systems (BioMEMS) (see [42] for a comprehensive
review of BioMEMS) has enabled the application of nano-
devices in biomedicine [43]. For the purpose of this review,
only BioMEMS with potential uses in regenerative medi-
cine, such as biocapsules, bioreactors, biosensors and
laboratory-on-a-chip, will be discussed and evaluated.
Biocapsules are nanodevices in the form of a shell
structure that enable the storage and transport of drugs
or molecules to be delivered or collected in a controlled
manner. Biocapsules can be fabricated to isolate specific
molecules. For example, Desai [44] has engineered micro-
fabricated biocapsules with a uniform pore-size distri-
bution that enabled the passage of molecules smaller
than 6 nm but excludedmolecules larger than 15 nm. Such
a device has a wide range of applications owing to its
versatility and simplicity in concept. Thus, the further
development of biocapsules can have a tremendous impact
in the future of regenerative medicine. They could be used
as an accurate and locally sensitive diagnostic tool, for
example, when another nanodevice is placed inside the
biocapsule, which would be able to analyse entrapped
molecules. Such a ‘smart’ biocapsule could therefore be
used as a real-time diagnostic tool and could also be used
for the prevention or treatment of a diseasewhen combined
with a drug-release system.
Bioreactors are devices that are used in vitro in which
regenerative cells and tissues are grown under controlled
monitoring and operating conditions (e.g. pH, tempera-
ture, pressure, fluidic and mechanical environment,
nutrient supply and waste control). These devices inte-
grate several types of BioMEMS into a single device to
optimise tissue regeneration and to provide specific con-
ditions for large-scale industrial applications [45]. Bio-
sensors and laboratory-on-a-chip are integrated inside
bioreactors to monitor and detect specific cellular pro-
cesses (Figure 3). Most biosensors available currently are
based on microtechnology but advances in nanotechnol-
ogy foresee the potential for many applications for nano-
biosensors. A nanobiosensor is a nanostructure that
reacts to the local environment by providing an optical
or electrical response. This response is a result of bio-
logical, chemical, mechanical or electrical reactions
occurring on the sensor. Examples of nanobiosensors
are quantum dots, fluorescent nanoparticles, metallic
nanoparticles, CNs [41], pH sensors or oxygen sensors
that use nanotechnology for locally discrete measure-
ments or a molecule-release sensor (such as release of
calcium or potassium) [46]. Energy supply of nanosensors
can be provided through the integration of motor proteins
that function through ATP [47]. Once nanobiosensors are
integrated into bioreactors, they would in theory be able
to regulate culture conditions automatically by feedback
loops and this would improve tissue regeneration con-
siderably.
Figure 3. Bioreactors for regenerative medicine. A 3D scaffold with cells is cultured within a bioreactor in which the microenvironment is controlled. The physical and
chemical stimuli, which are produced with the application of a controlled fluid flow within the scaffold, induce biochemical signals that are captured by a laboratory-on-a-
chip, in which several nanosensors can be integrated to detect pH, O2, ions, DNA or proteins. These data can be analysed in real-time to regulate the microenvironments
automatically through a feedback-loop mechanism.
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The prospect of replacing damaged tissuewith regenerated
tissue would impact and change medical science definitely
and radically. Today’s interest in applying nanotechnology
to regenerative medicine is growing owing to its capacity
for producing nanostructures that are able to mimic
natural tissues as well as nanoparticles for use in delivery
systems.
Regenerative medicine aspects that focus on TE have
evolved into two main strategies. The first strategy con-
sists of an elegant approach in which stem cells harvested
from the patient are expanded and seeded on 3D scaffolds
within a bioreactor. The resulting hybrid construct is then
implanted into the patient (together with growth factors)
as a tissue matrix. However, the need to harvest and
expand stem cells poses great efficacy and efficiency pro-
blems that define the success of the entire process.
The second strategy relies on the development of intel-
ligent materials that would be able to send signals to the
stem cells already present in the diseased or damaged
tissue niches that would then trigger the regeneration
process. Nanotechnology is a powerful tool for creating
these ‘smart’ materials. This approach is challenging
and is still far from being achieved. Among other advan-
tages, it would raise the possibility to have such cell-free
materials ready ‘off the shelf’ and to be able to use them as
and when required.Finally, because nanotechnology is a novel tool, the
concern about the safety of nanomaterials used in regen-
erative medicine for human health has not been addressed
in a sufficient and satisfactory manner. Before nanomater-
ials will be used in human applications, it will be necessary
to carry out consistent and comprehensive studies to
ensure their innocuousness.
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